A New Jersey Assembly committee has adopted an amendment to a psilocybin bill that aligns its provisions with a Senate companion version, removing language to more broadly legalize the psychedelic and instead focusing on therapeutic use.
The Assembly Health Committee on Monday took testimony from experts before approving the amendment to the Psilocybin Behavioral Health Access and Services Act, which is being sponsored by Assemblymembers Herb Conaway (D), Clinton Calabrese (D) and Anthony Verrelli (D).
This comes just over a week after a Senate committee revised and passed that chamber’s version of the psilocybin proposal from Senate President Nick Scutari (D) and others.
The intent of the proposal is to “deal with and address the very real deficiencies that we are finding in terms of treatment for those who are in distress and not yet not able to obtain therapeutic benefit by alternate means,” Conaway, who chairs the Assembly panel, said at Monday’s meeting. “We’ll see as we move forward how this bill shapes up.”
Initially, the legislation was introduced this year in identical form to what lawmakers proposed last session—a plan that included personal legalization provisions, which the recent amended versions takes out. Those components would have made it legal
Read full article on Marijuana Moment
